SCHEMBL23618342

SCHEMBL23618342

Fc1cccc(Nc2ccc3[nH]c(CNc4ccnc(C(F)(F)F)c4)nc3c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH2 P48735 4/20 0.41
▸ IDH1 O75874 4/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ TGFBR1 P36897 3/20 0.38
▸ MAPK14 Q16539 2/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ ABCB11 O95342 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ TBXA2R P21731 1/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ OPRM1 P35372 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ GRM4 Q14833 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30040258 1.00 IDH2 (0.41) IDH2IDH1KDM4ETGFBR1MAPK14
SCHEMBL25402812 0.91 CYP1A2 (0.42) IDH2IDH1HSD17B10KCNH2HDAC1
SCHEMBL30040328 0.91 CYP1A2 (0.42) IDH2IDH1HSD17B10KCNH2HDAC1
SCHEMBL26262043 0.86 TGFBR1 (0.44) KDM4ETGFBR1MAPK14GRM4
SCHEMBL26260734 0.83 NPC1 (0.40) HDAC1HDAC8HDAC6GRM4PDE10A
SCHEMBL26260641 0.83 ABCB1 (0.43) KDRGRM4PDE10A
SCHEMBL30041878 0.83 ABCB1 (0.43) KDRGRM4PDE10A
SCHEMBL30579942 0.80 HSD17B10 (0.39) IDH2IDH1KDM4EHSD17B10KCNH2
SCHEMBL21611957 0.79 CYP3A4 (0.45) TGFBR1KDRKCNH2PDE10A
SCHEMBL21614777 0.77 CYP3A4 (0.54) HSD17B10KCNH2HDAC1HDAC6PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286942-A1 NEW PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2023-09-14 — — US disclosed
WO-2021136803-A1 NEW PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-07-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286942-A1 NEW PqsR INVERSE AGONISTS QRFPR, P2RY11, GPR55 IDH2 3505/4885IDH1 3462/4885KDM4E 3563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback